Search - tctmd.com

Displaying 81 - 100 of 118

Sort: Relevancy | Date

Presentation TCT 2016

Occupational Hazards and Technologies to Address Them

Presenter: Ehtisham Mahmud, Kenneth Rosenfield, Emmanouil S. Brilakis

October 29, 2016

Presentation TCT 2016

Training Standards for New Technology: Professional Societies, Industry or FDA

Presenter: Ehtisham Mahmud, Kenneth Rosenfield, Daniel M. Kolansky

October 29, 2016

Presentation TCT 2016

Integration of Novel Technologies in the Cath Lab: An Industry Perspective

Presenter: Ehtisham Mahmud, Kenneth Rosenfield, Jason Fontana

October 29, 2016

Presentation TCT 2016

High Cost Technologies: How Do You Afford Them?

Presenter: Ehtisham Mahmud, Kenneth Rosenfield

October 29, 2016

News Features

Grumbling Over Bundling: Cardiologists React Warily to Plans for Lump-Sum Payments for Cardiac Care

Caitlin E. Cox

September 23, 2016

News Industry News

Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease

September 16, 2016

News Industry News

SurModics Announces First Patient Enrolled in IDE Study of SurVeil™ Drug-Coated Balloon

April 06, 2016

News Conference News ISC 2016

ACT I, CREST Support Carotid Stenting as Alternative to Surgery, but Larger Question Looms

Todd Neale

February 17, 2016

Presentation TCT 2015

Endovascular Interventions: Lower-Extremity, Aorta, Renal, and Carotid Disease

Presenter: Kenneth Rosenfield, Sahil A. Parikh

October 12, 2015

News Industry News

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

October 06, 2015

News Daily News

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

Yael L. Maxwell

June 26, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Daily News

LEVANT 2：DCB 治疗股腘动脉疾病的 1 年随访结果优于标准球囊成形术

Yael L. Maxwell

June 26, 2015

Presentation

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Presenter: Kenneth Rosenfield

June 25, 2015

News Industry News

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

June 25, 2015

News Featured Fellow

Stephen W. Waldo, MD

Yael L. Maxwell

December 16, 2014

News Industry News

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

October 10, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices III: Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Arne Schwindt

September 15, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices II: Atherectomy - Insights from The DEFINITE AR Trial

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gunnar Tepe

September 15, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Francesco Liistro

September 15, 2014

Advertisement

Occupational Hazards and Technologies to Address Them

Training Standards for New Technology: Professional Societies, Industry or FDA

Integration of Novel Technologies in the Cath Lab: An Industry Perspective

High Cost Technologies: How Do You Afford Them?

Grumbling Over Bundling: Cardiologists React Warily to Plans for Lump-Sum Payments for Cardiac Care

Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease

SurModics Announces First Patient Enrolled in IDE Study of SurVeil™ Drug-Coated Balloon

ACT I, CREST Support Carotid Stenting as Alternative to Surgery, but Larger Question Looms

Endovascular Interventions: Lower-Extremity, Aorta, Renal, and Carotid Disease

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

LEVANT 2：DCB 治疗股腘动脉疾病的 1 年随访结果优于标准球囊成形术

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

Stephen W. Waldo, MD

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

DCB and the Use of Ancillary Devices III: Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies

DCB and the Use of Ancillary Devices II: Atherectomy - Insights from The DEFINITE AR Trial

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content